SIMPLIFY the Hand Hygiene Procedure - Three Steps Versus Six Steps for Performing Hand Hygiene (SIMPLIFY Study)
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Dec 3, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The SIMPLIFY Study is looking at two different methods for hand hygiene to see which one helps healthcare workers wash their hands more effectively. Hand hygiene is crucial for preventing infections in hospitals. This trial will compare a simpler 3-step hand washing technique to the more detailed 6-step method recommended by the World Health Organization. By doing this, the study aims to find out if the shorter method encourages healthcare workers to clean their hands more often and properly.
To participate in this study, individuals need to be healthcare workers assigned to specific hospital wards during the study period. Unfortunately, people who do not work in healthcare won't be able to take part. The trial is not yet recruiting participants, but once it starts, healthcare workers will be asked to follow either the 3-step or 6-step method and share their experiences. This research could help improve hand hygiene practices in hospitals, making them safer for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Health Care Workers (HCW) working at the randomized wards during the pre-defined timeframe
- Exclusion Criteria:
- • Individuals, who are no HCWs
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sarah Tschudin Sutter, Prof.Dr.med.
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials